A cryptic three-way translocation t(10;19;11)(p12.31;q13.31;q23.3) with a derivative Y-chromosome in an infant with acute myeloblastic leukemia (M5b)

Gene
Moneeb A K OthmanThomas Liehr

Abstract

Acute myeloid leukemia (AML) is a heterogeneous disease characterized by the malignant transformation of hematopoietic precursors to a pathogenic cell clone. Chromosomal band 11q23 harboring MLL (=mixed lineage leukemia) gene is known to be involved in rearrangements with variety of genes as activating partners of MLL in different AML subtypes. Overall, an unfavorable prognosis is associated with MLL abnormalities. Here we investigated an 11-month-old male presenting with hyperleukocytosis being diagnosed with AML subtype FAB-M5b. In banding cytogenetics a der(19)t(19;?)(q13.3;?) and del(Y)(q11.23) were found as sole aberrations. Molecular cytogenetics revealed that the MLL gene was disrupted and even partially lost due to a t(10;19;11)(p12.31;q13.31;q23.3), an MLL/MLLT10 fusion appeared, and the der(Y) was an asymmetric inverted duplication with breakpoints in Yp11.2 and Yq11.23. The patient got hematopoietic stem cell transplantation from his haploidentical mother. Still three months afterwards 15% of blasts were detected in bone marrow and later the patient was lost during follow-up. The present case highlights the necessity to exclude MLL rearrangements, even when there seems to be no actual hint from banding cytogenetics.

References

Feb 1, 1992·Cancer Genetics and Cytogenetics·I PetkovićM Nakić
Sep 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·J CorralA Karpas
Feb 22, 2005·Cancer Genetics and Cytogenetics·Nathalie Douet-GuilbertMarc De Braekeleer
Aug 30, 2006·Cancer Genetics and Cytogenetics·Irina StasevichOlga Aleinikova
Dec 21, 2007·Leukemia·D Caudell, P D Aplan
Feb 8, 2008·The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society·Anja WeiseNadezda Kosyakova
Feb 2, 2010·Hematology/oncology Clinics of North America·Jeffrey E RubnitzFranklin O Smith
Dec 24, 2010·JAMA : the Journal of the American Medical Association·Carolyn J HildrethRichard M Glass
May 14, 2011·Leukemia·B V BalgobindM M Van den Heuvel-Eibrink
Aug 9, 2012·Leukemia Research·Cecile BorelChristian Récher
May 1, 2013·Leukemia·C MeyerR Marschalek
May 16, 2013·Blood·Lucia BrandimarteCristina Mecucci
Aug 2, 2014·Clinical Lymphoma, Myeloma & Leukemia·Courtney D DiNardoHagop M Kantarjian

❮ Previous
Next ❯

Citations

Sep 12, 2017·Hematology·Saeid ShahrabiNajmaldin Saki

❮ Previous
Next ❯

Related Concepts

Related Feeds

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.

AML: Role of LSD1 by CRISPR (Keystone)

Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.

B-Cell Leukemia (Keystone)

B-cell leukemia includes various types of lymphoid leukemia that affect B cells. Here is the latest research on B-cell leukemia.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

© 2022 Meta ULC. All rights reserved